We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCHB
1751
Mechanics Bancorp
MCHB
$3.72B
| $2.91M | ﹤0.01% |
71,424
-4,664
| -6% | -$201K |
|
1752
John B. Sanfilippo & Son
JBSS
$976M
| $2.9M | ﹤0.01% |
32,784
+258
| +0.8% | +$23.5K |
|
|
MNTV
1753
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $2.9M | ﹤0.01% |
137,648
-6,166
| -4% | -$119K |
|
1754
Marcus & Millichap
MMI
$1.2B
| $2.9M | ﹤0.01% |
74,545
-3,048
| -4% | -$114K |
|
|
NP
1755
DELISTED
Neenah, Inc. Common Stock
NP
| $2.9M | ﹤0.01% |
57,763
-2,887
| -5% | -$154K |
|
1756
Inovio Pharmaceuticals
INO
$69.6M
| $2.89M | ﹤0.01% |
26,005
+7,454
| +40% | +$716K |
|
1757
AdvanSix
ASIX
$543M
| $2.89M | ﹤0.01% |
96,858
-5,334
| -5% | -$160K |
|
|
SLCA
1758
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.88M | ﹤0.01% |
249,525
-13,091
| -5% | -$152K |
|
1759
Warrior Met Coal
HCC
$4.73B
| $2.88M | ﹤0.01% |
167,566
-13,372
| -7% | -$233K |
|
1760
Otter Tail
OTTR
$3.91B
| $2.88M | ﹤0.01% |
59,000
-237
| -0.4% | -$11.3K |
|
1761
Red Rock Resorts
RRR
$3.68B
| $2.87M | ﹤0.01% |
67,634
-20,644
| -23% | -$816K |
|
1762
Pilgrim's Pride
PPC
$6.56B
| $2.87M | ﹤0.01% |
129,289
-5,825
| -4% | -$139K |
|
|
CMRC
1763
Commerce.com Inc Series 1
CMRC
$192M
| $2.86M | ﹤0.01% |
44,100
+4,331
| +11% | +$245K |
|
|
LGF.B
1764
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.86M | ﹤0.01% |
156,414
+35,680
| +30% | +$547K |
|
1765
AdaptHealth
AHCO
$806M
| $2.86M | ﹤0.01% |
104,395
+28,938
| +38% | +$825K |
|
1766
Microvision
MVIS
$76.1M
| $2.86M | ﹤0.01% |
+11,385
| New | +$2.8M |
|
|
ENDP
1767
DELISTED
Endo International plc
ENDP
| $2.85M | ﹤0.01% |
610,113
+26,796
| +5% | +$154K |
|
1768
Helix Energy Solutions
HLX
$1.45B
| $2.85M | ﹤0.01% |
498,512
-25,639
| -5% | -$135K |
|
1769
DMC Global
BOOM
$154M
| $2.85M | ﹤0.01% |
50,606
+2,211
| +5% | +$122K |
|
|
KYNB
1770
Kyntra Bio
KYNB
$28.3M
| $2.84M | ﹤0.01% |
4,261
+215
| +5% | +$124K |
|
|
RC
1771
Ready Capital
RC
$279M
| $2.83M | ﹤0.01% |
178,617
-5,505
| -3% | -$81.5K |
|
|
SRNE
1772
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.82M | ﹤0.01% |
291,417
+8,903
| +3% | +$70.9K |
|
1773
Gray Television
GTN
$440M
| $2.82M | ﹤0.01% |
120,616
+1,297
| +1% | +$28.1K |
|
1774
Maravai LifeSciences
MRVI
$922M
| $2.82M | ﹤0.01% |
67,553
+3,690
| +6% | +$143K |
|
1775
Workhorse Group
WKHS
$35.2M
| $2.81M | ﹤0.01% |
56
+8
| +17% | +$296K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.